IBDEI0IV ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8491,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8491,1,3,0)
;;=3^Rheumatic Heart Diseases NEC
;;^UTILITY(U,$J,358.3,8491,1,4,0)
;;=4^I09.89
;;^UTILITY(U,$J,358.3,8491,2)
;;=^5007060
;;^UTILITY(U,$J,358.3,8492,0)
;;=I47.1^^39^400^24
;;^UTILITY(U,$J,358.3,8492,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8492,1,3,0)
;;=3^Supraventricular Tachycardia
;;^UTILITY(U,$J,358.3,8492,1,4,0)
;;=4^I47.1
;;^UTILITY(U,$J,358.3,8492,2)
;;=^5007223
;;^UTILITY(U,$J,358.3,8493,0)
;;=I48.0^^39^400^15
;;^UTILITY(U,$J,358.3,8493,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8493,1,3,0)
;;=3^Paroxysmal Atrial Fibrillation
;;^UTILITY(U,$J,358.3,8493,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,8493,2)
;;=^90473
;;^UTILITY(U,$J,358.3,8494,0)
;;=I49.5^^39^400^23
;;^UTILITY(U,$J,358.3,8494,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8494,1,3,0)
;;=3^Sick Sinus Syndrome
;;^UTILITY(U,$J,358.3,8494,1,4,0)
;;=4^I49.5
;;^UTILITY(U,$J,358.3,8494,2)
;;=^110404
;;^UTILITY(U,$J,358.3,8495,0)
;;=I49.8^^39^400^3
;;^UTILITY(U,$J,358.3,8495,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8495,1,3,0)
;;=3^Cardiac Arrhythmias
;;^UTILITY(U,$J,358.3,8495,1,4,0)
;;=4^I49.8
;;^UTILITY(U,$J,358.3,8495,2)
;;=^5007236
;;^UTILITY(U,$J,358.3,8496,0)
;;=I49.9^^39^400^2
;;^UTILITY(U,$J,358.3,8496,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8496,1,3,0)
;;=3^Cardiac Arrhythmia,Unspec
;;^UTILITY(U,$J,358.3,8496,1,4,0)
;;=4^I49.9
;;^UTILITY(U,$J,358.3,8496,2)
;;=^5007237
;;^UTILITY(U,$J,358.3,8497,0)
;;=R00.1^^39^400^1
;;^UTILITY(U,$J,358.3,8497,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8497,1,3,0)
;;=3^Bradycardia,Unspec
;;^UTILITY(U,$J,358.3,8497,1,4,0)
;;=4^R00.1
;;^UTILITY(U,$J,358.3,8497,2)
;;=^5019164
;;^UTILITY(U,$J,358.3,8498,0)
;;=I34.1^^39^400^14
;;^UTILITY(U,$J,358.3,8498,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8498,1,3,0)
;;=3^Nonrheumatic Mitral Valve Prolapse
;;^UTILITY(U,$J,358.3,8498,1,4,0)
;;=4^I34.1
;;^UTILITY(U,$J,358.3,8498,2)
;;=^5007170
;;^UTILITY(U,$J,358.3,8499,0)
;;=D68.4^^39^401^1
;;^UTILITY(U,$J,358.3,8499,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8499,1,3,0)
;;=3^Acquired Coagulation Factor Deficiency
;;^UTILITY(U,$J,358.3,8499,1,4,0)
;;=4^D68.4
;;^UTILITY(U,$J,358.3,8499,2)
;;=^2235
;;^UTILITY(U,$J,358.3,8500,0)
;;=D59.9^^39^401^2
;;^UTILITY(U,$J,358.3,8500,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8500,1,3,0)
;;=3^Acquired Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,8500,1,4,0)
;;=4^D59.9
;;^UTILITY(U,$J,358.3,8500,2)
;;=^5002330
;;^UTILITY(U,$J,358.3,8501,0)
;;=C91.00^^39^401^5
;;^UTILITY(U,$J,358.3,8501,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8501,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,8501,1,4,0)
;;=4^C91.00
;;^UTILITY(U,$J,358.3,8501,2)
;;=^5001762
;;^UTILITY(U,$J,358.3,8502,0)
;;=C91.01^^39^401^4
;;^UTILITY(U,$J,358.3,8502,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8502,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8502,1,4,0)
;;=4^C91.01
;;^UTILITY(U,$J,358.3,8502,2)
;;=^5001763
;;^UTILITY(U,$J,358.3,8503,0)
;;=C92.01^^39^401^7
;;^UTILITY(U,$J,358.3,8503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8503,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8503,1,4,0)
;;=4^C92.01
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0IV 3744 printed Sep 23, 2025@19:25:32 Page 2
IBDEI0IV ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8491,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,8491,1,3,0)
+4 ;;=3^Rheumatic Heart Diseases NEC
+5 ;;^UTILITY(U,$J,358.3,8491,1,4,0)
+6 ;;=4^I09.89
+7 ;;^UTILITY(U,$J,358.3,8491,2)
+8 ;;=^5007060
+9 ;;^UTILITY(U,$J,358.3,8492,0)
+10 ;;=I47.1^^39^400^24
+11 ;;^UTILITY(U,$J,358.3,8492,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,8492,1,3,0)
+14 ;;=3^Supraventricular Tachycardia
+15 ;;^UTILITY(U,$J,358.3,8492,1,4,0)
+16 ;;=4^I47.1
+17 ;;^UTILITY(U,$J,358.3,8492,2)
+18 ;;=^5007223
+19 ;;^UTILITY(U,$J,358.3,8493,0)
+20 ;;=I48.0^^39^400^15
+21 ;;^UTILITY(U,$J,358.3,8493,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,8493,1,3,0)
+24 ;;=3^Paroxysmal Atrial Fibrillation
+25 ;;^UTILITY(U,$J,358.3,8493,1,4,0)
+26 ;;=4^I48.0
+27 ;;^UTILITY(U,$J,358.3,8493,2)
+28 ;;=^90473
+29 ;;^UTILITY(U,$J,358.3,8494,0)
+30 ;;=I49.5^^39^400^23
+31 ;;^UTILITY(U,$J,358.3,8494,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,8494,1,3,0)
+34 ;;=3^Sick Sinus Syndrome
+35 ;;^UTILITY(U,$J,358.3,8494,1,4,0)
+36 ;;=4^I49.5
+37 ;;^UTILITY(U,$J,358.3,8494,2)
+38 ;;=^110404
+39 ;;^UTILITY(U,$J,358.3,8495,0)
+40 ;;=I49.8^^39^400^3
+41 ;;^UTILITY(U,$J,358.3,8495,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,8495,1,3,0)
+44 ;;=3^Cardiac Arrhythmias
+45 ;;^UTILITY(U,$J,358.3,8495,1,4,0)
+46 ;;=4^I49.8
+47 ;;^UTILITY(U,$J,358.3,8495,2)
+48 ;;=^5007236
+49 ;;^UTILITY(U,$J,358.3,8496,0)
+50 ;;=I49.9^^39^400^2
+51 ;;^UTILITY(U,$J,358.3,8496,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,8496,1,3,0)
+54 ;;=3^Cardiac Arrhythmia,Unspec
+55 ;;^UTILITY(U,$J,358.3,8496,1,4,0)
+56 ;;=4^I49.9
+57 ;;^UTILITY(U,$J,358.3,8496,2)
+58 ;;=^5007237
+59 ;;^UTILITY(U,$J,358.3,8497,0)
+60 ;;=R00.1^^39^400^1
+61 ;;^UTILITY(U,$J,358.3,8497,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,8497,1,3,0)
+64 ;;=3^Bradycardia,Unspec
+65 ;;^UTILITY(U,$J,358.3,8497,1,4,0)
+66 ;;=4^R00.1
+67 ;;^UTILITY(U,$J,358.3,8497,2)
+68 ;;=^5019164
+69 ;;^UTILITY(U,$J,358.3,8498,0)
+70 ;;=I34.1^^39^400^14
+71 ;;^UTILITY(U,$J,358.3,8498,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,8498,1,3,0)
+74 ;;=3^Nonrheumatic Mitral Valve Prolapse
+75 ;;^UTILITY(U,$J,358.3,8498,1,4,0)
+76 ;;=4^I34.1
+77 ;;^UTILITY(U,$J,358.3,8498,2)
+78 ;;=^5007170
+79 ;;^UTILITY(U,$J,358.3,8499,0)
+80 ;;=D68.4^^39^401^1
+81 ;;^UTILITY(U,$J,358.3,8499,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,8499,1,3,0)
+84 ;;=3^Acquired Coagulation Factor Deficiency
+85 ;;^UTILITY(U,$J,358.3,8499,1,4,0)
+86 ;;=4^D68.4
+87 ;;^UTILITY(U,$J,358.3,8499,2)
+88 ;;=^2235
+89 ;;^UTILITY(U,$J,358.3,8500,0)
+90 ;;=D59.9^^39^401^2
+91 ;;^UTILITY(U,$J,358.3,8500,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,8500,1,3,0)
+94 ;;=3^Acquired Hemolytic Anemia,Unspec
+95 ;;^UTILITY(U,$J,358.3,8500,1,4,0)
+96 ;;=4^D59.9
+97 ;;^UTILITY(U,$J,358.3,8500,2)
+98 ;;=^5002330
+99 ;;^UTILITY(U,$J,358.3,8501,0)
+100 ;;=C91.00^^39^401^5
+101 ;;^UTILITY(U,$J,358.3,8501,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,8501,1,3,0)
+104 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
+105 ;;^UTILITY(U,$J,358.3,8501,1,4,0)
+106 ;;=4^C91.00
+107 ;;^UTILITY(U,$J,358.3,8501,2)
+108 ;;=^5001762
+109 ;;^UTILITY(U,$J,358.3,8502,0)
+110 ;;=C91.01^^39^401^4
+111 ;;^UTILITY(U,$J,358.3,8502,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,8502,1,3,0)
+114 ;;=3^Acute Lymphoblastic Leukemia,In Remission
+115 ;;^UTILITY(U,$J,358.3,8502,1,4,0)
+116 ;;=4^C91.01
+117 ;;^UTILITY(U,$J,358.3,8502,2)
+118 ;;=^5001763
+119 ;;^UTILITY(U,$J,358.3,8503,0)
+120 ;;=C92.01^^39^401^7
+121 ;;^UTILITY(U,$J,358.3,8503,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,8503,1,3,0)
+124 ;;=3^Acute Myeloblastic Leukemia,In Remission
+125 ;;^UTILITY(U,$J,358.3,8503,1,4,0)
+126 ;;=4^C92.01
